BusinessEpiPen gets a new competitor: FDA approves anaphylaxis nasal...

EpiPen gets a new competitor: FDA approves anaphylaxis nasal spray



EpiPen gets a new competitor: FDA approves anaphylaxis nasal spray

Neffy is the first no-needle treatment for a severe allergic reaction.

Good news for those who suffer from severe allergic reactions: a nasal spray containing epinephrine rather than a needle can now treat those frightening moments.



Original Source Link

Latest News

Lineup, Dates, Ticket Prices & More – Hollywood Life

It’s time to start planning all your fabulous OOTDs, for the two-weekends-long New Orleans Jazz Fest 2025. Find...

Why are we still talking about toilets? Because we must.

Safe and accessible sanitation is an equality issue, but also a health one that affects us all. In a...

Bitcoin Traders Turn Bearish Despite Price Recovery Above $97,000, Here Are The Numbers

Este artículo también está disponible en español. The Bitcoin price has recovered above $97,000, providing a bullish outlook for...

Canada warns of ‘tit-for-tat’ tariffs on US if Donald Trump imposes levies

Unlock the White House Watch newsletter for freeYour guide to what the 2024 US election means for Washington...

The FTC Suing John Deere Is a Tipping Point for Right-to-Repair

Today, the US Federal Trade Commission filed a lawsuit against farming equipment manufacturer Deere & Company—makers of the...

Must Read

- Advertisement -

You might also likeRELATED
Recommended to you